XAIR Tuesday earnings, price breakout last week, still way off 52 week highs, updates coming on LungFitPro

*XAIR*

I Bought in long at 7-8 avg among a few accounts and it's under the radar imo. trades low avg volume. Broke out of a decending triangle TA pattern if your into TA the chart looks hot.

https://finviz.com/quote.ashx?t=XAIR

Rumor mill is on the earning date getting pushed back for a reason, and an FDA approval is coming in next 48 hrs, but who knows, probably hype and company has legs so just a side note.

Pros
-Way off it's highs, no negitive news, victim of the broader market imo.

-Nitric Oxide treatments trials seem very bullish. Lung fit pro device is showing safe and effective FDA trials.

https://www.globenewswire.com/news-release/2022/04/25/2427973/0/en/Beyond-Air-Presents-Positive-Safety-and-Efficacy-Data-for-Inhaled-Nitric-Oxide-to-Treat-COVID-19-at-ECCMID-2022.html

-announced promising new in vivo and in vitro data that support the potential of the company’s novel gaseous nitric oxide (gNO) therapy to treat various types of solid tumors. These data were presented at the American Association for Cancer Research (AACR) Annual Meeting 2022.

https://www.globenewswire.com/news-release/2022/04/25/2427973/0/en/Beyond-Air-Presents-Positive-Safety-and-Efficacy-Data-for-Inhaled-Nitric-Oxide-to-Treat-COVID-19-at-ECCMID-2022.html

-Insider buys out pacing the few sells over last 12 month.

Cons:

-Biotechnology company in a rising rate environment burning cash each quarter.

• ultimate payoff could get unhinged by negitive trials or FDA report, but info again very bullish.

-Brutal market conditions for raising capital down the road if the time lines get pushed back, but cash mgmt hasn't been an issue imo.

What am I missing, I really like Beyond air long term.